P. Schein
- Biomaterials top 10%
-
- Cancer Treatment and Pharmacology 3
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 2
- Small Animals top 10%
-
- Cardiac electrophysiology and arrhythmias 2
- Chemotherapy-induced cardiotoxicity and mitigation 2
-
- Liver Disease Diagnosis and Treatment 2
-
- Ion channel regulation and function 2
-
- Radiomics and Machine Learning in Medical Imaging 1
-
- Acute Myeloid Leukemia Research 1
- Co-authors
- Erik HermanA RahmanV J FerransVincent T. DeVitaM J O'ConnellJohn W. NewmanPeter H. WiernikJ. L. Ziegler
- Cited by
- BiomaterialsOncologyPharmacology
- Journals
- Toxicology and Applied Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Experimental Biology and Medicine (2 papers)
- Partner nations
- United StatesItalyUganda
In The Last Decade
P. Schein
16 papers receiving 512 citations
Peers
Comparison fields: 5 of 90
- Biomaterials 111
- Oncology 196
- Pharmacology 49
- Small Animals 40
- Cardiology and Cardiovascular Medicine 114
Countries citing papers authored by P. Schein
This map shows the geographic impact of P. Schein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schein more than expected).
Fields of papers citing papers by P. Schein
This network shows the impact of papers produced by P. Schein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schein. The network helps show where P. Schein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Schein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 3 | |
| 2 | 1995 | 2 | |
| 3 | 1986 | 49 | |
| 4 | 1985 | 6 | |
| 5 | Toxicity evaluation of doxorubicin entrapped in cardiolipin liposomes in mice. Abstr. | 1983 | 3 |
| 6 | Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. | 1983 | 143 |
| 7 | Animal toxicology for early clinical trials with anticancer agents. | 1981 | 47 |
| 8 | 1978 | 27 | |
| 9 | 1976 | 10 | |
| 10 | The role of carbamoylation in nitrosourea toxicity and antitumor activity in mice. Abstr. | 1976 | 1 |
| 11 | 1974 | 138 | |
| 12 | 1973 | 13 | |
| 13 | 1973 | 18 | |
| 14 | 1972 | 1 | |
| 15 | 1970 | 89 | |
| 16 | 1970 | 5 | |
| 17 | 1970 | 8 | |
| 18 | 1969 | 15 |
About P. Schein
P. Schein is a scholar working on Pharmacology, Geriatrics and Gerontology, Physiology, Oncology and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 578 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Ion channel regulation and function (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Biomaterials (111 citations), Oncology (196 citations), Pharmacology (49 citations), Small Animals (40 citations) and Cardiology and Cardiovascular Medicine (114 citations). P. Schein has collaborated with scholars based in United States, Italy and Uganda. Frequent co-authors include Erik Herman, A Rahman, V J Ferrans, Vincent T. DeVita, M J O'Connell, John W. Newman, Peter H. Wiernik, J. L. Ziegler, I T Magrath and S M Hubbard. Their work appears in journals such as Toxicology and Applied Pharmacology, Cancer Chemotherapy and Pharmacology, Experimental Biology and Medicine, Cancer and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.